| Line Item | 2025-10-31 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $1.23B | +1.0% | +4.4% |
| Cost of Revenue | $271.8M | -0.5% | -4.3% |
| Gross Profit | $958.1M | +1.5% | +7.2% |
| R&D Expense | $210.1M | +1.8% | -5.8% |
| SG&A Expense | $94.7M | +23.2% | -24.9% |
| Operating Income | $310.4M | -3.5% | +69.8% |
| Pre-tax Income | $794.7M |
| Line Item | 2025-10-31 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $1.22B | +1.4% | -4.5% |
| Accounts Receivable | $417.7M | -19.2% | -8.8% |
| Current Assets | $8.71B | +0.6% | +2.1% |
| Total Assets | $11.39B | +3.1% | +6.7% |
| Current Liabilities | $1.96B | +0.6% | +5.7% |
| Total Liabilities |
| Line Item | 2025-10-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | $1.63B | — | — |
| Capital Expenditures | $48.9M | — | — |
| Investing Cash Flow | -$330.2M | — | — |
| Financing Cash Flow | -$1.45B | — | — |
| Free Cash Flow | $1.59B | — | — |
| +77.3% |
| +183.4% |
| Income Tax | $181.8M | +103.0% | +147.9% |
| Net Income | $612.9M | +70.9% | +196.0% |
| EPS (Basic) | $2.05 | +72.3% | +206.0% |
| EPS (Diluted) | $2.01 | +73.3% | +204.5% |
| $2.10B |
| +0.5% |
| +5.2% |
| Stockholders' Equity | $9.29B | +3.8% | +7.0% |